Radiological Reporting of Brain Atrophy in MRI: Real-Life Comparison Between Narrative Reports, Semiquantitative Scales and Automated Software-Based Volumetry
- PMID: 40428239
- PMCID: PMC12110413
- DOI: 10.3390/diagnostics15101246
Radiological Reporting of Brain Atrophy in MRI: Real-Life Comparison Between Narrative Reports, Semiquantitative Scales and Automated Software-Based Volumetry
Abstract
Background: Accurate assessment of brain atrophy is essential in the diagnosis and monitoring of brain aging and neurodegenerative disorders. Radiological methods range from narrative reporting to semi-quantitative visual rating scales (VRSs) and fully automated volumetric software. However, their integration and consistency in clinical practice remain limited. Methods: In this retrospective study, brain MRI images of 43 patients were evaluated. Brain atrophy was assessed by extrapolating findings from narrative radiology reports, three validated VRSs (MTA, Koedam, Pasquier), and Pixyl.Neuro.BV, a commercially available volumetric software platform. Agreement between methods was assessed using intraclass correlation coefficients (ICCs), Cohen's kappa, Spearman's correlation, and McNemar tests. Results: Moderate correlation was found between narrative reports and VRSs (ρ = 0.55-0.69), but categorical agreement was limited (kappa = 0.21-0.30). Visual scales underestimated atrophy relative to software (mean scores: VRSs = 0.196; software = 0.279), while reports tended to overestimate. Agreement between VRSs and software was poor (kappa = 0.14-0.33), though MTA showed a significant correlation with hippocampal volume. Agreement between reports and software was lowest for global atrophy. Conclusions: Narrative reports, while common in practice, show low consistency with structured scales and quantitative software, especially in subtle cases. VRSs improve standardization but remain subjective and less sensitive. Integrating structured scales and volumetric tools into clinical workflows may enhance diagnostic accuracy and consistency in dementia imaging.
Keywords: MRI; automated software; brain atrophy; brain volumetry; dementia.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Brain MRI volumetry and atrophy rating scales as predictors of amyloid status and eligibility for anti-amyloid treatment in a real-world memory clinic setting.J Neurol. 2024 Dec 21;272(1):84. doi: 10.1007/s00415-024-12853-9. J Neurol. 2024. PMID: 39708177 Free PMC article.
-
Automated quantitative MRI volumetry reports support diagnostic interpretation in dementia: a multi-rater, clinical accuracy study.Eur Radiol. 2021 Jul;31(7):5312-5323. doi: 10.1007/s00330-020-07455-8. Epub 2021 Jan 15. Eur Radiol. 2021. PMID: 33452627 Free PMC article.
-
Combining semi-quantitative rating and automated brain volumetry in MRI evaluation of patients with probable behavioural variant of fronto-temporal dementia: an added value for clinical practise?Neuroradiology. 2023 Jun;65(6):1025-1035. doi: 10.1007/s00234-023-03133-w. Epub 2023 Mar 3. Neuroradiology. 2023. PMID: 36867204
-
Visual atrophy rating scales and amyloid PET status in an Alzheimer's disease clinical cohort.Ann Clin Transl Neurol. 2023 Apr;10(4):619-631. doi: 10.1002/acn3.51749. Epub 2023 Mar 5. Ann Clin Transl Neurol. 2023. PMID: 36872523 Free PMC article. Review.
-
Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales.J Neurol Neurosurg Psychiatry. 2015 Nov;86(11):1225-33. doi: 10.1136/jnnp-2014-310090. Epub 2015 Apr 14. J Neurol Neurosurg Psychiatry. 2015. PMID: 25872513 Review.
References
-
- Amiri H., de Sitter A., Bendfeldt K., Battaglini M., Gandini Wheeler-Kingshott C.A.M., Calabrese M., Geurts J.J.G., Rocca M.A., Sastre-Garriga J., Enzinger C., et al. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage Clin. 2018;19:466–475. doi: 10.1016/j.nicl.2018.04.023. - DOI - PMC - PubMed
-
- Zivadinov R., Bergsland N., Korn J.R., Dwyer M.G., Khan N., Medin J., Price J.C., Weinstock-Guttman B., Silva D., Group M.-M.S. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS. AJNR Am. J. Neuroradiol. 2018;39:289–295. doi: 10.3174/ajnr.A5442. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources